Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$0.54 - $2.74 $762,516 - $3.87 Million
-1,412,067 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$2.33 - $3.37 $2.99 Million - $4.32 Million
1,283,087 Added 994.8%
1,412,067 $3.77 Million
Q2 2021

Aug 16, 2021

SELL
$2.6 - $3.65 $4.76 Million - $6.69 Million
-1,832,687 Reduced 93.42%
128,980 $368,000
Q1 2021

May 14, 2021

BUY
$2.73 - $4.5 $5.36 Million - $8.83 Million
1,961,667 New
1,961,667 $6.73 Million
Q3 2019

Nov 14, 2019

SELL
$1.48 - $2.52 $65,917 - $112,238
-44,539 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.39 - $4.61 $150,987 - $205,324
44,539 New
44,539 $192,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $333M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.